Research on new class of treatments for ovarian cancer receives $725,000 in funding from Ovarian Cancer Canada to become “clinical trial-ready”
HALIFAX, Nova Scotia, May 04, 2026 (GLOBE NEWSWIRE) — To mark World Ovarian Cancer Day, Ovarian Cancer Canada is announcing a $725,000 investment to fuel critical ovarian cancer research. Led by globally respected Canadian immunologist, Dr. Jeanette Boudreau, investment in this research project will prepare powerful natural killer (NK) cell immunotherapy to move into clinical […]
Original Source
Read the full article at Financialpost →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.